» Articles » PMID: 34206674

In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage

Overview
Publisher MDPI
Date 2021 Jul 2
PMID 34206674
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In this paper, silk sericin nanocarriers with a very low size range were obtained by nanoprecipitation. Sericin nanoparticles were loaded with doxorubicin, and they were considered a promising tool for breast cancer therapy. The chemistry, structure, morphology, and size distribution of nanocarriers were investigated by Fourier transformed infrared spectroscopy (FTIR-ATR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM), and dynamic light scattering (DLS). Morphological investigation and DLS showed the formation of sericin nanoparticles in the 25-40 nm range. FTIR chemical characterization showed specific interactions of protein-doxorubicin-enzymes with a high influence on the drug delivery process and release behavior. The biological investigation via breast cancer cell line revealed a high activity of nanocarriers in cancer cells by inducing significant DNA damage.

Citing Articles

Innovative Processing and Sterilization Techniques to Unlock the Potential of Silk Sericin for Biomedical Applications.

Veiga A, Ramirez-Jimenez R, Santos-Rosales V, Garcia-Gonzalez C, Aguilar M, Rojo L Gels. 2025; 11(2).

PMID: 39996657 PMC: 11854797. DOI: 10.3390/gels11020114.


Sericin coats of silk fibres, a degumming waste or future material?.

Yuan Y, Nasri M, Manayi A, Zhang J, Wu C, Jeon T Mater Today Bio. 2024; 29:101306.

PMID: 39534681 PMC: 11554926. DOI: 10.1016/j.mtbio.2024.101306.


Dendrimer Platforms for Targeted Doxorubicin Delivery-Physicochemical Properties in Context of Biological Responses.

Szota M, Szwedowicz U, Rembialkowska N, Janicka-Klos A, Doveiko D, Chen Y Int J Mol Sci. 2024; 25(13).

PMID: 39000306 PMC: 11241532. DOI: 10.3390/ijms25137201.


Progress in silk and silk fiber-inspired polymeric nanomaterials for drug delivery.

Pacheco M, Eccles L, Davies N, Armada J, Cakley A, Kadambi I Front Chem Eng. 2024; 4.

PMID: 38487791 PMC: 10939129. DOI: 10.3389/fceng.2022.1044431.


Toxicological effects of dimethlybenzeneanthracene in Balb C mice and pharmacological intervention by silk sericin-conjugated silver nanoparticles.

Mumtaz S, Ali S, Pervaiz A, Awan U, Nauroze T, Kanwal L Sci Prog. 2024; 107(1):368504231221670.

PMID: 38232951 PMC: 10798092. DOI: 10.1177/00368504231221670.


References
1.
Altman G, Diaz F, Jakuba C, Calabro T, Horan R, Chen J . Silk-based biomaterials. Biomaterials. 2002; 24(3):401-16. DOI: 10.1016/s0142-9612(02)00353-8. View

2.
Limayem Blouza I, Charcosset C, Sfar S, Fessi H . Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Int J Pharm. 2006; 325(1-2):124-31. DOI: 10.1016/j.ijpharm.2006.06.022. View

3.
Radu I, Hudita A, Zaharia C, Stanescu P, Vasile E, Iovu H . Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer. Front Pharmacol. 2017; 8:508. PMC: 5539237. DOI: 10.3389/fphar.2017.00508. View

4.
Aramwit P, Bang N, Ratanavaraporn J, Ekgasit S . Green synthesis of silk sericin-capped silver nanoparticles and their potent anti-bacterial activity. Nanoscale Res Lett. 2014; 9(1):79. PMC: 3996096. DOI: 10.1186/1556-276X-9-79. View

5.
Akturk O, Gun Gok Z, Erdemli O, Yigitoglu M . One-pot facile synthesis of silk sericin-capped gold nanoparticles by UVC radiation: Investigation of stability, biocompatibility, and antibacterial activity. J Biomed Mater Res A. 2019; 107(12):2667-2679. DOI: 10.1002/jbm.a.36771. View